Literature DB >> 8495462

Red blood cell magnesium levels in migraine patients.

V Gallai1, P Sarchielli, P Morucci, G Abbritti.   

Abstract

In the last few years, it has been suggested that magnesium plays a central role in establishing a threshold for migraine attacks and in intervening with the pathogenetic mechanisms involved in their onset. Accordingly, we determined red blood cell magnesium levels in adult migraine patients with and without aura interictally and in some of them also ictally. In comparison with normal subjects, migraineurs with and without aura had significantly lower red blood cell magnesium levels in the interictal period. Ictal red blood cell magnesium levels did not differ from the interictal values. Low red blood cell magnesium levels could be a peripheral expression of the reduced brain magnesium concentration observed in migraine patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495462     DOI: 10.1046/j.1468-2982.1993.1302094.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  Should magnesium be given to every migraineur? No.

Authors:  Arpad Pardutz; Laszlo Vecsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

2.  Nutraceuticals in Acute and Prophylactic Treatment of Migraine.

Authors:  Oved Daniel; Alexander Mauskop
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 3.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

Review 4.  Cortical spreading depression as a target for anti-migraine agents.

Authors:  Cinzia Costa; Alessandro Tozzi; Innocenzo Rainero; Letizia Maria Cupini; Paolo Calabresi; Cenk Ayata; Paola Sarchielli
Journal:  J Headache Pain       Date:  2013-07-23       Impact factor: 7.277

Review 5.  Non-Pharmacological Approaches for Migraine.

Authors:  Francesca Puledda; Kevin Shields
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.